Use of64Cu-labeled Fibronectin Domain with EGFR-Overexpressing Tumor Xenograft: Molecular Imaging

Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Positive Tumor with a64Cu Labeled Affibody Protein

(2010) Zheng Miao et al.   BIOCONJUGATE CHEMISTRY

Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size

(2010) C. Zahnd et al.   CANCER RESEARCH

Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma

(2010) G. Niu et al.   CLINICAL CANCER RESEARCH

Stability and CDR Composition Biases Enrich Binder Functionality Landscapes

(2010) Benjamin J. Hackel et al.   JOURNAL OF MOLECULAR BIOLOGY

Evaluation of a 64Cu-Labeled Cystine-Knot Peptide Based on Agouti-Related Protein for PET of Tumors Expressing  v 3 Integrin

(2010) L. Jiang et al.   JOURNAL OF NUCLEAR MEDICINE

Adnectins: engineered target-binding protein therapeutics

(2010) D. Lipovsek   PROTEIN ENGINEERING DESIGN & SELECTION

Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF

(2010) Heewa Kareem et al.   TUMOR BIOLOGY

Positron Emission Tomography (PET) Imaging with [11C]-Labeled Erlotinib: A Micro-PET Study on Mice with Lung Tumor Xenografts

(2009) A. A. Memon et al.   CANCER RESEARCH

Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects

(2009) R. H. Kimura et al.   CANCER RESEARCH

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount

(2009) Vladimir Tolmachev et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

(2009) G. Niu et al.   JOURNAL OF NUCLEAR MEDICINE

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

(2009) V. Tolmachev et al.   JOURNAL OF NUCLEAR MEDICINE

Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules

(2009) G. Kramer-Marek et al.   JOURNAL OF NUCLEAR MEDICINE

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

(2009) A. Orlova et al.   JOURNAL OF NUCLEAR MEDICINE

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

(2009) M. M. Schmidt et al.   MOLECULAR CANCER THERAPEUTICS

[11C]Gefitinib ([11C]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma

(2009) Ming-Rong Zhang et al.   MOLECULAR IMAGING AND BIOLOGY

64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors

(2009) Zhen Cheng et al.   MOLECULAR IMAGING AND BIOLOGY

Influence of the Molecular Charge on the Biodistribution of Bombesin Analogues Labeled with the [99mTc(CO)3]-Core

(2008) Elisa García Garayoa et al.   BIOCONJUGATE CHEMISTRY

Receptor-Binding, Biodistribution, and Metabolism Studies of 64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors

(2008) Wen Ping Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules

(2008) Z. Cheng et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT

(2008) L. O. T. Gainkam et al.   JOURNAL OF NUCLEAR MEDICINE

SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression

(2008) Lieven Huang et al.   MOLECULAR IMAGING AND BIOLOGY

Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules

(2007) Sara Ahlgren et al.   BIOCONJUGATE CHEMISTRY